mr

Moderna

MRNA
NASDAQ
$45.09

Is Moderna financially strong?

Moderna has an exceptionally strong balance sheet with a conservative debt-to-equity ratio of 0.07x. The company could comfortably weather a severe economic downturn. This financial fortress provides strategic flexibility and reduces risk for long-term shareholders.